Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

NasdaqCM - Delayed Quote USD

Nutriband Inc. (NTRBW)

Compare

3.1000

-0.0700

(-2.21%)

At close: 4:00:00 PM EST

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it received the Certificate of Registration from the United States Patent and Trademark Office (USPTO) on Feb 18, 2025, for trademark registration Number 7,692,920, covering the mark "Nutriband™." The Trademark registration covers Goods/Services: Class: 042 Product research and development, scientific research and development; bio

GlobeNewswire 7 days ago

NTRB
+0.83%
NTRBW
-2.21%
When Will Nutriband Inc. (NASDAQ:NTRB) Breakeven?

Nutriband Inc. ( NASDAQ:NTRB ) is possibly approaching a major achievement in its business, so we would like to shine...

Simply Wall St. 10 days ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with Kindeva Drug Delivery to develop Aversa™ Fentanyl which combines Nutriband’s Aversa™ abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch. ORLANDO, Fla., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription t

GlobeNewswire 15 days ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board

ORLANDO, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced World and European Wrestling Gold medalist and Olympic Silver medalist Anastasia Nichita has been appointed to its Product Advisory Board to expand the Nutriband Brand and promote it’s over the counter sports and consumer products internationally. "We are very excited to add Anastasia to our team. We believe her experience

GlobeNewswire 17 days ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and AustraliaORLANDO, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it received a Notice of Allowance fr

GlobeNewswire 21 days ago

NTRB
+0.83%
NTRBW
-2.21%
Why Nutriband Inc (NTRB) Is Skyrocketing So Far In 2025

We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Nutriband Inc (NASDAQ:NTRB) stands against the other healthcare stocks. The healthcare sector is staging a comeback so far in 2025 after two years of underperformance. These […]

Insider Monkey 24 days ago

NTRBW
-2.21%
Shareholders in Nutriband (NASDAQ:NTRB) are in the red if they invested five years ago

Generally speaking long term investing is the way to go. But along the way some stocks are going to perform badly. To...

Simply Wall St. last month

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Issues Letter to Shareholders

ORLANDO, Fla., Dec. 31, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders highlighting the company’s achievements in 2024 and the outlook for 2025. Dear Fellow Shareholders, As we close out 2024, I want to extend my deepest gratitude to you, our loyal shareholders, for your continued trust and support. This year has been one of exceptional progress, strategic execution, and transformative milesto

GlobeNewswire last month

NTRB
+0.83%
NTRBW
-2.21%
Nutriband extends Chinese patent to Macao for AVERSA technology

Nutriband (NTRB) has completed the registration requirements to extend its Chinese patent to Macao for its patent entitled, “Abuse and Misuse Deterrent Transdermal Systems,” which protects its AVERSA abuse deterrent transdermal technology. The Macao IP Office has assigned number J/9010 to the patent with an entry date of December 17, 2024. Macao is a Special Administrative Region of the People’s Republic of China which affords it a high degree of autonomy with its own patent system and patent la

TipRanks 2 months ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Nutriband’s abuse-deterrent platform technology is now patented in 46 countries and territories covering major global markets. Nutriband is targeting to file for FDA approval for AVERSA™ Fentanyl in the first half of 2025. ORLANDO, Fla., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has completed the registration requirements to extend its Chinese pate

GlobeNewswire 2 months ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

ORLANDO, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today reported its financial results for the third quarter ended October 31, 2024. The Company reported a strong cash position at quarter end, reinforcing its ability to advance the development of its lead product, AVERSA™ Fentanyl, with an NDA submission targeted for first half of 2025. Nutriband is continuing to expand its kinesiology tape contract manufacturing services through its Pocono Pharma subsi

GlobeNewswire 2 months ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th

ORLANDO, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (Nasdaq:NTRB)(Nasdaq:NTRBW) today announced that it will be presenting at the Noble Conference taking place December 3rd and 4th at the Florida Atlantic University in Boca Raton, FL. Company President and Chairman Serguei Melnik will present at 1.30 PM in Conference room 3 on December 4th to primarily discuss the company’s AVERSA technology. Information about the Conference can be found here – https://nobleconference.comDetails of M

GlobeNewswire 2 months ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

AVERSA Fentanyl has the potential to be the world's first and only abuse-deterrent opioid patchORLANDO, Fla., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has received a Notice of Publication of the Registration and Grant of a Standard Patent (R) from the Hong Kong Intellectual Property Department for patent application entitled, “Abuse and Misuse Det

GlobeNewswire 3 months ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

ORLANDO, FL / ACCESSWIRE / October 31, 2024 /Nutriband (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that theChinese National Intellectual Property Administrant (CNIPA) has fully issued its patent titled "Abuse and Misuse Deterrent Transdermal System" ...

ACCESS Newswire 3 months ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

The approved product will be exclusively distributed through Farmavision S.A. throughout Costa Rica ORLANDO, FL / ACCESSWIRE / October 17, 2024 /Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that it has received approval from the Costa ...

ACCESS Newswire 4 months ago

NTRB
+0.83%
NTRBW
-2.21%
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

ORLANDO, FL / ACCESSWIRE / October 2, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, is pleased to invite investors to a webinar on October 17, 2024, at 4:15 p.m. ET. The exclusive event, hosted ...

ACCESS Newswire 4 months ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Notice of Allowance received from Chinese National Intellectual Property Administration (CNIPA) for the patent application covering its Platform AVERSA™ abuse deterrent transdermal technology Nutriband abuse-deterrent transdermal technology consists ...

ACCESS Newswire 5 months ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

Nutriband signs trademark licensing agreement for Bitrex® brand denatonium benzoate, the most bitter substance in the world, as an aversive agent for its Aversa™ Fentanyl abuse deterrent fentanyl transdermal patch Nutriband abuse-deterrent transdermal ...

ACCESS Newswire 5 months ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Inc. Authorizes $1M Share Buyback Program

ORLANDO, FL / ACCESSWIRE / September 16, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced a share repurchase program to buy back up to $1,000,000 of its common stock. As of September 16, 2024, the Company had 11,106,185 shares of common ...

ACCESS Newswire 5 months ago

NTRB
+0.83%
NTRBW
-2.21%
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

ORLANDO, FL / ACCESSWIRE / September 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has reported its financial results for the second quarter ended July 31, 2024. The Company reported a strong cash position at quarter end, reinforcing its ability ...

ACCESS Newswire 5 months ago

NTRB
+0.83%
NTRBW
-2.21%

Performance Overview

Return	NTRBW	S&P 500
YTD	+121.43%	+1.24%
1-Year	+1,092.31%	+17.45%
3-Year	+23.02%	+36.14%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Nutriband Inc. (NTRBW)

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

When Will Nutriband Inc. (NASDAQ:NTRB) Breakeven?

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

Why Nutriband Inc (NTRB) Is Skyrocketing So Far In 2025

Shareholders in Nutriband (NASDAQ:NTRB) are in the red if they invested five years ago

Nutriband Issues Letter to Shareholders

Nutriband extends Chinese patent to Macao for AVERSA technology

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

Nutriband Inc. Authorizes $1M Share Buyback Program

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Performance Overview